Reuters logo
BRIEF-Sanofi Explores Combination Treatments For Multiple Myeloma In New Late-Stage Trials
December 7, 2017 / 1:22 PM / in 7 days

BRIEF-Sanofi Explores Combination Treatments For Multiple Myeloma In New Late-Stage Trials

Dec 7 (Reuters) - Sanofi Sa:

* SANOFI EXPLORES COMBINATION TREATMENTS FOR MULTIPLE MYELOMA IN NEW LATE-STAGE TRIALS

* SANOFI - PHASE 3 TRIALS WILL EVALUATE ISATUXIMAB, AN ANTI-CD38 ANTIBODY, IN COMBINATION WITH OTHER CANCER TREATMENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below